ResMed faces an uncertain future as GLP-1 weight loss drugs threaten to reduce demand for sleep apnea devices, creating a complex investment dilemma for shareholders of the CPAP machine leader.
The use of electrical stimulation of the upper airway to treat patients with obstructive sleep apnea (OSA) is supported by low-quality evidence.
For anaesthetists, optimising ventilation settings during surgery is a fundamental aspect of patient care. Adjusting positive ...